NeuroSigma | 合法醫療器材資訊網
TheMonarch®eTNS®SystemistheFirstFDAClearedDeviceforTreatingPediatricADHD.TheMonarcheTNSSystemisindicatedforthetreatmentofpediatric ...
The Monarch eTNS System is indicated for the treatment of pediatric Attention Deficit Hyperactivity Disorder (ADHD) as a monotherapy in patients ages 7 through 12 years old who are not currently taking prescription ADHD medications. The device is used for patient treatment by prescription only and is intended to be used in the home under the supervision of a caregiver during periods of sleep.
The most common side effects observed with eTNS use are: drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue. No serious adverse events have been associated with use of the device. Please consult the instructions for use for additional information.
Latest NewsOctober 03, 2023 NeuroSigma Announces HS...
Monarch eTNS System for Treating Pediatric ADHD | 合法醫療器材資訊網
NeuroSigma | 合法醫療器材資訊網
NeuroSigma Announces Publication of ADHD Clinical Trial ... | 合法醫療器材資訊網
NeuroSigma Company | 合法醫療器材資訊網
NeuroSigma Continues to Build a Substantial Global ... | 合法醫療器材資訊網
NeuroSigma Journal Articles | 合法醫療器材資訊網
NeuroSigma Press Releases | 合法醫療器材資訊網
NeuroSigma Research | 合法醫療器材資訊網
NeuroSigma Team | 合法醫療器材資訊網
【“紐可適”橫膈節律系統】許可證字號:衛部醫器輸字第032976號
器材品名:“紐可適”橫膈節律系統許可證字號:衛部醫器輸字第032976號註銷狀態:註銷日期:註銷理由:有效日期:2024/11/17發證日期...